Veterinary Medicines

Bultavo 3, Suspension for injection

Authorised
  • Bluetongue virus, serotype 3, strain Bio-93:BTV3, Inactivated
Download as PDF

Product identification

Medicine name:
Bultavo 3, Suspension for injection
BULTAVO 3 SUSPENSION INJECTABLE POUR OVINS ET BOVINS
Active substance:
  • Bluetongue virus, serotype 3, strain Bio-93:BTV3, Inactivated
Target species:
  • Sheep
  • Cattle
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Bluetongue virus, serotype 3, strain Bio-93:BTV3, Inactivated
    320.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA08
  • QI04AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Glass Vial 10 x 10.0 millilitre(s)
  • Glass Vial 1 x 10.0 millilitre(s)
  • Glass Vial 1 x 50.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)
  • Plastic (HDPE) Vial 10 x 10.0 millilitre(s)
  • Plastic (HDPE) Vial 1 x 10.0 millilitre(s)
  • Plastic (HDPE) Vial 1 x 50.0 millilitre(s)
  • Plastic (HDPE) Vial 1 x 100.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Applications in exceptional circumstances (Article 25 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5480517 0/2025
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0207/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/05/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/05/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."